What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

The GOOD and the BAD Side of GLP-1s and What to Do If You Get Caught…

Ken Fujioka

Weightloss in Menopause

Susan Brian

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

Can I Ever Be Cured? Strategies for Remission of Type 2 Diabetes

Keck School of Medicine of USC

R. Retnakaran

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Tirzepatide Updates

Diana Isaacs

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Mounjaro Update 2024

Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

Wegovy 2024 Updates

Susan Brian